Wikipedia:WikiProject WikiFundi Content/Dengue fever

WikiProject WikiFundi Content/Dengue fever
Other namesdengue, breakbone fever
Pronunciation
  • UK: /ˈdɛŋɡ/ or US: /ˈdɛŋɡ/
SpecialtyInfectious disease
Preview warning: Page using Template:Infobox medical condition with unknown parameter "Alt"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "MeshName"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "MedlinePlus"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "MeshNumber"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "eMedicineTopic"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "OMIM"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "eMedicineSubj"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "Name"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "Image"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "ICD10"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "ICD9"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "DiseasesDB"
Preview warning: Page using Template:Infobox medical condition with unknown parameter "Caption"

Dengue fever is a mosquito-borne tropical disease caused by the dengue virus.[1] Symptoms typically begin three to fourteen days after infection.[2] This may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash.[1][2] Recovery generally takes less than two to seven days.[1] In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs.[2]

Dengue is spread by several species of mosquito of the Aedes type, principally A. aegypti.[1] The virus has five different types;[3] infection with one type usually gives lifelong immunity to that type, but only short-term immunity to the others. Subsequent infection with a different type increases the risk of severe complications.[1] A number of tests are available to confirm the diagnosis including detecting antibodies to the virus or its RNA.[2]

A novel vaccine for dengue fever has been approved in three countries, but it is not yet commercially available.[4] Prevention is by reducing mosquito habitat and limiting exposure to bites. This may be done by getting rid of or covering standing water and wearing clothing that covers much of the body.[1] Treatment of acute dengue is supportive and includes giving fluid either by mouth or intravenously for mild or moderate disease. For more severe cases blood transfusion may be required.[2] About half a million people require admission to hospital a year.[1] Nonsteroidal anti-inflammatory drug (NSAIDs) such as ibuprofen should not be used.[2]

Dengue has become a global problem since the Second World War and is common in more than 110 countries.[5][6] Each year between 50 and 528 million people are infected and approximately 10,000 to 20,000 die.[7][8][9][10] The earliest descriptions of an outbreak date from 1779.[6] Its viral cause and spread were understood by the early 20th century.[11] Apart from eliminating the mosquitoes, work is ongoing for medication targeted directly at the virus.[12]

  1. ^ a b c d e f g "Dengue and severe dengue Fact sheet N°117". WHO. May 2015. Retrieved 3 February 2016.
  2. ^ a b c d e f Kularatne, SA (15 September 2015). "Dengue fever". BMJ (Clinical Research Ed.). 351: h4661. doi:10.1136/bmj.h4661. PMID 26374064. S2CID 1680504.
  3. ^ Normile D (2013). "Surprising new dengue virus throws a spanner in disease control efforts". Science. 342 (6157): 415. doi:10.1126/science.342.6157.415. PMID 24159024.
  4. ^ Maron, Dina (30 December 2015). "First Dengue Fever Vaccine Gets Green Light in 3 Countries". Scientific American. Retrieved 3 February 2016.
  5. ^ Ranjit S, Kissoon N (January 2011). "Dengue hemorrhagic fever and shock syndromes". Pediatr. Crit. Care Med. 12 (1): 90–100. doi:10.1097/PCC.0b013e3181e911a7. PMID 20639791. S2CID 10135251.
  6. ^ a b Gubler DJ (July 1998). "Dengue and dengue hemorrhagic fever". Clin. Microbiol. Rev. 11 (3): 480–96. doi:10.1128/CMR.11.3.480. PMC 88892. PMID 9665979.
  7. ^ Whitehorn J, Farrar J (2010). "Dengue". Br. Med. Bull. 95: 161–73. doi:10.1093/bmb/ldq019. PMID 20616106.
  8. ^ Bhatt S, Gething PW, Brady OJ, et al. (April 2013). "The global distribution and burden of dengue". Nature. 496 (7446): 504–7. Bibcode:2013Natur.496..504B. doi:10.1038/nature12060. PMC 3651993. PMID 23563266.
  9. ^ Carabali, M; Hernandez, LM; Arauz, MJ; Villar, LA; Ridde, V (30 July 2015). "Why are people with dengue dying? A scoping review of determinants for dengue mortality". BMC Infectious Diseases. 15: 301. doi:10.1186/s12879-015-1058-x. PMC 4520151. PMID 26223700. Open access icon
  10. ^ Stanaway, JD; Shepard, DS; Undurraga, EA; Halasa, YA; Coffeng, LE; Brady, OJ; Hay, SI; Bedi, N; Bensenor, IM; Castañeda-Orjuela, CA; Chuang, TW; Gibney, KB; Memish, ZA; Rafay, A; Ukwaja, KN; Yonemoto, N; Murray, CJ (10 February 2016). "The global burden of dengue: an analysis from the Global Burden of Disease Study 2013". The Lancet. Infectious Diseases. 16 (6): 712–723. doi:10.1016/S1473-3099(16)00026-8. PMC 5012511. PMID 26874619.
  11. ^ Henchal EA, Putnak JR (October 1990). "The dengue viruses". Clin. Microbiol. Rev. 3 (4): 376–96. doi:10.1128/CMR.3.4.376. PMC 358169. PMID 2224837.
  12. ^ Noble CG, Chen YL, Dong H, et al. (March 2010). "Strategies for development of Dengue virus inhibitors". Antiviral Res. 85 (3): 450–62. doi:10.1016/j.antiviral.2009.12.011. PMID 20060421.